ArticleKidney international2024
Pre-transplant anti-nephrin antibodies are specific predictors of recurrent diffuse podocytopathy in the kidney allograft.
Abstract read
In one paragraph
Article in Kidney international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed.
- Anti-nephrin antibodies in pediatric nephrotic syndrome: a new paradigm.Pediatric nephrology (Berlin, Germany) · 2026Review
- Anti-nephrin autoantibodies in post-transplant recurrence of focal segmental glomerulosclerosis: a review.Renal failure · 2026Review
- Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.Kidney international · 2026Article
- Ten tips for the diagnosis and management of nephrotic syndrome.Clinical kidney journal · 2026Review
- Antinephrin, Antipodocin, and Anti-Kirrel1 Autoantibodies in Posttransplant Recurrent FSGS.Kidney international reports · 2026Article
- Dual anti-CD20/anti-CD38 therapy for severe recurrent FSGS with longitudinal anti-nephrin assessment.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026Article
- Anti-nephrin antibodies are not enriched in patients with primary and posttransplant recurrent podocytopathies.The Journal of clinical investigation · 2026Observational
- Mechanisms of Podocyte Injury in Kidney Allografts.Kidney360 · 2026Review
- Living Donor Kidney Transplantation in High-Recurrence Kidney Diseases: Precision Risk Stratification and Management.Kidney international reports · 2026Review
- Anti-nephrin autoantibodies in post-transplant recurrent focal segmental glomerulosclerosis: diagnostic advances and future directions.Clinical and experimental nephrology · 2026Review
- Effect of Steroids on Anti-nephrin Autoantibodies and B cells in Minimal Change Disease.Kidney international reports · 2026Article
- Daratumumab for Treatment of Refractory Podocytopathy: A Case Report.Kidney medicine · 2026Article
- Daratumumab as rescue therapy in refractory recurrent FSGS after kidney transplantation: a case series.Transplant international : official journal of the European Society for Organ Transplantation · 2026Article
- Opportunities and challenges in recurrent diffuse podocytopathy post-transplantation: the critical value of the definition.Frontiers in immunology · 2026Review
- Podocytopathies.Nature reviews. Disease primers · 2025Review
- Vincristine Treatment Protects Against Podocyte Damage in Focal Segmental Glomerulosclerosis.Kidney international reports · 2025Article
- Emerging roles of non-coding RNAs in idiopathic nephrotic syndrome: a narrative review.BMC nephrology · 2025Review
- Serum Factors in Primary Podocytopathies.Antibodies (Basel, Switzerland) · 2025Review
- Recurrence of Glomerular Diseases (GN) After Kidney Transplantation: A Narrative Review.Journal of clinical medicine · 2025Review
- [Nephrotic syndrome].Innere Medizin (Heidelberg, Germany) · 2025Review
Corrections and comments
- Commented on by
Authors and funding
20 authors.
Ibrahim BatalDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA. Electronic address: ib2349@cumc.columbia.edu.
Andrew J B WattsDepartment of Medicine, Division of Nephrology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Jean-Baptiste GibierDepartment of Pathology, Centre Hospitalier Universitaire de Lille, Lille, France.
Aghiles HamrounDepartment of Medicine, Division of Nephrology, Centre Hospitalier Universitaire de Lille, Lille, France; Department of Medicine, Division of Public Health Epidemiology, Centre Hospitalier Universitaire de Lille, Lille, France; Institut Pasteur de Lille, Inserm, University Lille, Lille, France.
Isabelle TopInsitutut d'Immunologie-HLA, Centre Hospitalier Universitaire de Lille, Lille, France.
François ProvotDepartment of Medicine, Division of Nephrology, Centre Hospitalier Universitaire de Lille, Lille, France.
Keith KellerDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts, USA.
Xiaoyi YeDepartment of Medicine, Division of Nephrology, Hartford Hospital, Hartford, Connecticut, USA.
Hilda E FernandezDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Rita LealDepartment of Medicine, Division of Nephrology, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.
Nicole K AndeenDepartment of Pathology, Oregon Health & Science University, Portland, Oregon, USA.
Russell J CrewDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Geoffrey K DubeDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Elena-Rodica VasilescuDepartment of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.
Lloyd E RatnerDepartment of Surgery, Columbia University Irving Medical Center, New York, New York, USA.
Nicole BowmanDepartment of Medicine, Division of Nephrology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Andrew S BombackDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Simone Sanna-CherchiDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Krzysztof KirylukDepartment of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York, USA.
Astrid WeinsDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA. Electronic address: AWEINS@BWH.HARVARD.EDU.
Funding
Integrating large scale genomics and functional studies to accelerate FSGS/NS discoveryRC2DK122397 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HILDEBRANDT, FRIEDHELM, POLLAK, MARTIN R. · 2020 to 2024
$7.4MGenomics of glomerular diseaseRC2DK116690 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KIRYLUK, KRZYSZTOF, KRETZLER, MATTHIAS · 2018 to 2022
$5.0MGenetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney AllograftR01DK135671 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Ibrahim Batal · 2023 to 2026
$1.5MNIDDK NIH HHS R01 DK135671NIDDK NIH HHS RC2 DK116690NIDDK NIH HHS RC2 DK122397
Abstract
PubMed holds no abstract for this paper.
Indexed as
AllograftsKidney TransplantationAdultAutoantibodiesFemaleHumansMaleMembrane ProteinsMiddle AgedPodocytesRecurrenceAutoantibodiesMembrane Proteinsanti-nephrin antibodiesdiffuse podocytopathyfocal segmental glomerular sclerosiskidney allograftminimal change diseaserecurrent disease
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.